The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the reported paresis associated with the hemiplegia appears to be due to the cerebral infarction.The reported cerebrovascular accident (stroke with permanent impairment) associated with the infarction appears to be due to the thrombosis.The cause of the reported thrombosis/thrombus could not be determined.The reported patient effects of thrombosis/thrombus and cerebrovascular accident, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported hospitalization and medication required were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|
This is filed to report a stroke, thrombus and paralysis, requiring intervention.It was reported that on (b)(6) 2023, a mitraclip procedure was performed to treat functional mitral regurgitation (mr) grade 3 with an enlarged atria.One mitraclip was implanted successfully, reducing the mr to grade 1-2.Two days later, it was noted that the patient suffered a cerebral infarction.Medication was given to treat the thrombosis.In addition, it was noted that the patient suffered hemiplegia as a result.No additional information was provided.
|